[Intestinal loss syndromes].
D001427:Bacterial Toxins / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003108:Colonic Diseases / Q000503:physiopathology / Q000628:therapy; D003840:Deoxycholic Acid / Q000627:therapeutic use; D003967:Diarrhea / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007457:Iodine Radioisotopes; D008286:Malabsorption Syndromes / Q000378:metabolism*; D011453:Prostaglandins / Q000378:metabolism; D011504:Protein-Losing Enteropathies / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism; D014883:Water-Electrolyte Imbalance / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000652:urine
D001427:Bacterial Toxins; D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D011453:Prostaglandins; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; D003840:Deoxycholic Acid; D002792:Cholestyramine Resin; D014660:Vasoactive Intestinal Peptide
Intestinale Verlustsyndrome.